Page last updated: 2024-09-02

alpha-hydroxymetoprolol and Kidney Diseases

alpha-hydroxymetoprolol has been researched along with Kidney Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ismail, R; Teh, LK1
John, VA; Lloyd, P; Signy, M; Smith, SE1

Trials

1 trial(s) available for alpha-hydroxymetoprolol and Kidney Diseases

ArticleYear
The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients.
    Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiovascular Diseases; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Kidney Diseases; Male; Metoprolol; Middle Aged; Pharmacogenetics; Polymorphism, Genetic

2006

Other Studies

1 other study(ies) available for alpha-hydroxymetoprolol and Kidney Diseases

ArticleYear
The effect of impaired renal function on the pharmacokinetics of metoprolol after single administration of a 14/190 metoprolol OROS system.
    American heart journal, 1990, Volume: 120, Issue:2

    Topics: Administration, Oral; Delayed-Action Preparations; Humans; Kidney Diseases; Male; Metoprolol; Osmolar Concentration

1990